ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 96

Epidemiology and Health Services Use For Osteoarthritis By First Nations People In Alberta, Canada

Cheryl Barnabe1, Allyson Jones2, Ed Enns3, Don Voaklander4, Christine Peschken5, Joanne Homik4, John Esdaile6, Sasha Bernatsky7, Brenda Hemmelgarn8 and Deborah Marshall9, 1Medicine, Community Health Sciences, University of Calgary, Calgary, AB, Canada, 2Department of Physical Therapy, University of Alberta, Edmonton, AB, Canada, 3Alberta Bone and Joint Health Institute, Calgary, AB, Canada, 4University of Alberta, Edmonton, AB, Canada, 5Medicine & Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada, 6Medicine, University of British Columbia, Vancouver, BC, Canada, 7Clinical Epidemiology, Research Institute of the McGill University Health Ctre, Montreal, QC, Canada, 8Division of Nephrology, University of Calgary, Calgary, AB, Canada, 9University of Calgary, Calgary, AB, Canada

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Epidemiologic methods, health disparities and osteoarthritis, Native Americans

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Epidemiology and Health Services I

Session Type: Abstract Submissions (ACR)

Background/Purpose: Self-reported survey data and a single provincial administrative data source have previously indicated that the First Nations (FN) population in Canada has a 1.5 fold higher prevalence of osteoarthritis (OA), but the health services use by this population is unknown. Our objective was to determine whether OA prevalence and healthcare use in Alberta, Canada varies by FN status.

Methods: Using population-based healthcare administrative data (years 1993 to 2010), we defined a cohort of patients with OA (2 physician claims within 2 years or 1 hospitalization with diagnosis code ICD9 715x, or ICD10 M15-19). FN patients were identified based on premium payer status and represent 3.8% of the Alberta population. OA prevalence (fiscal year 2007/2008) and outpatient visits for OA to primary care physicians, specialists (orthopedic surgeons and rheumatologists), and arthroplasty (hip or knee) are reported for FN and non-FN populations.

Results: The age and sex standardized OA prevalence in FN Albertans is twice that of the non-FN population (161.0 vs 78.2 cases/1,000 population, standardized rate ratio 2.06; 95%CI 2.00-2.12). Prevalence is highest in people residing in rural locations and in females (Table 1).

Table 1. Prevalence of Osteoarthritis in Alberta (/1,000 population)

First Nations

non-First Nations

Overall Prevalence

Age and sex standardized

161.0

78.2

Location of Residence

Rural

186.7

88.5

Urban

135.9

76.2

Sex

Females

184.9

93.1

Males

148.8

72.3

Per year, FN persons had a mean of 3.4 primary care outpatient visits specifically for OA (20.3% of FN total primary care contacts) compared to 1.6 visits per year for non-FN persons (14.4% of non-FN total primary care contacts) (p<0.001). Contact with specialists was significantly lower for FN persons, with one-third fewer outpatient visits to orthopedics and rheumatology compared to non-FN persons (Table 2).

Table 2. Healthcare Use for Osteoarthritis in Alberta (/1,000 person-years)

First Nations

non-First Nations

Primary Care Visits

3380.1

1557.4

Orthopedic Surgeons

218.3

405.0

Rheumatologists

39.0

51.4

FN with OA were two-thirds less likely to have arthroplasty of the hip or knee. This did not appear to be driven by the presence of other medical comorbidities (Table 3).

Table 3. Arthroplasty Rates for Osteoarthritis in Alberta (/1,000 person-years)

First Nations

non-First Nations

Overall

8.1

26.4

Diabetes

8.6

23.5

Any Comorbidity

8.8

25.7

Conclusion: We demonstrate disparities in OA care in FN persons given an estimated 2-fold higher disease prevalence from administrative data sources. While this finding may be driven in part by an increased probability of diagnosis through frequent primary care contact, it is unlikely to account for the large gap in use of specialty services and arthroplasty in FN compared to non-FN persons. This care gap may be due to access barriers for FN patients.


Disclosure:

C. Barnabe,
None;

A. Jones,
None;

E. Enns,
None;

D. Voaklander,
None;

C. Peschken,
None;

J. Homik,
None;

J. Esdaile,
None;

S. Bernatsky,
None;

B. Hemmelgarn,
None;

D. Marshall,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/epidemiology-and-health-services-use-for-osteoarthritis-by-first-nations-people-in-alberta-canada/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology